Sep 26, 2016 10:56 am UTC| Business
- Primary endpoint achieved in both Epidiolex doses with high statistical significance compared to placebo - - Today’s data represents the third positive Phase 3 pivotal trial for Epidiolex reported in 2016 - - Data...
BioCryst Closes $23 Million Senior Credit Facility
Sep 26, 2016 10:47 am UTC| Business
Cash runway extended to early 2018; Facility to be repaid with RAPIVAB revenues RESEARCH TRIANGLE PARK, N.C., Sept. 26, 2016 -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that the Company has closed...
Lanolin Market Size Expected To Reach $227.7 Million By 2024: Grand View Research, Inc.
Sep 26, 2016 10:45 am UTC| Business
San Francisco, Sept. 26, 2016 -- The global lanolin market is expected to reach USD 227.7 million by 2024, according to a new report by Grand View Research, Inc. Rising demand in personal care cosmetics sector is...
Cambrex to Acquire PharmaCore Inc., to Expand Clinical Stage API Capabilities
Sep 26, 2016 10:45 am UTC| Business
EAST RUTHERFORD, N.J., Sept. 26, 2016 -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that it has agreed to...
Sep 26, 2016 10:35 am UTC| Business
Dublin, Sept. 26, 2016 -- Research and Markets has announced the addition of the "Internet of Things Technology Market - Forecast to 2022" report to their offering. According to the...
Sep 26, 2016 10:35 am UTC| Business
Dublin, Sept. 26, 2016 -- Research and Markets has announced the addition of the "Industrial Adhesives Market by Type (Water-based Adhesives, Solvent-based Adhesives, Hot-Melt Adhesives, Pressure...
Kombucha Market Projected To Reach $4.46 Billion By 2024: Grand View Research, Inc.
Sep 26, 2016 10:30 am UTC| Business
San Francisco, Sept. 26, 2016 -- The global kombucha market is expected to reach USD 4.46 billion by 2024, according to a new report by Grand View Research, Inc. Increasing awareness of the health benefits...